Allena Pharmaceuticals, Inc. (ALNA)

$0.1212

-0.01 (-5.02%)
Rating:
Recommendation:
Buy
Symbol ALNA
Price $0.1212
Beta 1.149
Volume Avg. 27.56M
Market Cap 13.056M
Shares () -
52 Week Range 0.068-1.17
1y Target Est -
DCF Unlevered ALNA DCF ->
DCF Levered ALNA LDCF ->
ROE -192.04% Strong Sell
ROA -151.95% Strong Sell
Operating Margin -
Debt / Equity 87.09% Buy
P/E -
P/B 0.93 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ALNA news


Dr. Louis Brenner
Healthcare
Biotechnology
NASDAQ Capital Market

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.